1. Home
  2. VRA vs BTAI Comparison

VRA vs BTAI Comparison

Compare VRA & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.20

Market Cap

60.6M

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
BTAI
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
49.2M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
VRA
BTAI
Price
$2.20
$1.90
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$4.00
$32.80
AVG Volume (30 Days)
2.3M
578.0K
Earning Date
12-11-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
$752,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.33
$416.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$1.17
52 Week High
$4.73
$9.26

Technical Indicators

Market Signals
Indicator
VRA
BTAI
Relative Strength Index (RSI) 46.55 44.03
Support Level $1.39 $1.82
Resistance Level $2.06 $2.30
Average True Range (ATR) 0.21 0.17
MACD -0.07 0.00
Stochastic Oscillator 48.80 11.78

Price Performance

Historical Comparison
VRA
BTAI

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: